References
- Scott AB, Kennedy RA, Stubbs HA. Botulinum toxin injection as a treatment for blepharospasm. Arch Ophthalmol 1985; 103: 347–350
- Ashizawa T, Patten BM, Jankovic J. Meige's syndrome. South Med J 1980; 73: 863–866
- Jancovic J, Ford J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings. Ann Neurol 1983; 13: 402–411
- Jancovic J, Patten BM. Blepharospasm and autoimmune diseases. Movement Disorders 1987; 2: 159–163
- Kurlan SR, Jancovic J, Rubin A, Patten B, Griggs R, Shoulson I. Coexistent Meige's syndrome and myasthenia gravis. Arch Neurol 1987; 44: 1057–1060
- Nutt JG, Carter J, De Garmo P, Hammertad JP. Meige syndrome and thyroid dysfunction. Neurology 1984; 34: 222, suppl.I
- Grandas F, Quinn N, Elston J, Marsden CD. Letter to the Editor. Movement Disorders 1990; 5: 89
- Burke RE, Fahn S, Jancovic J, et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982; 32: 1335–1346
- Corin MS, Elizan TS, Bender MB. Oculomotor function in patients with Parkinson's disease. J Neurol Sci 1972; 15: 251–265
- Klawans HL, Erlich MA. Observations on the mechanism of parkinsonian blepharospasm and its treatment with L-dopa. Eur Neurol 1970; 3: 365–372
- Malinovsky V. Benign essential blepharospasm. J Am Optometric Ass 1987; 58: 646–651
- Weiner WJ, Nausieda PA, Glantz RH. Meige syndrome (blepharo-spasm-oromandibular dystonia) after long-term neuroleptic therapy. Neurology 1981; 31: 1555–1556
- Agid Y, Javoy-Agid F. Peptides and Parkinson's disease. Trends Neurosci 1985; 8: 30–35
- Nappi G, Petraglia F, Martignoni F. Beta-endorphin cerebrospinal fluid decrease in untreated Parkinsonian patients. Neurology 1985; 35: 1371–1374
- Sandyk R. The endogenous opioid system in neurological disorders of the basal ganglia. Life Sci 1985; 37: 1655–1663
- Genazzani AR, Romano G, Brilli G, Petraglia F. Neuroendocrine control of plasma beta-endorphin secretion. Opioid Peptides in Biological Fluids, AR Genazzani, M Negri. The Parthenon Publishing Group, Casterton HallUK 1989; 11–16
- Panerai AE. Beta-endorphin: fifteen years after. Opioid Peptides in Biological Fluids, AR Genazzani, M Negri. The Parthenon Publishing Group, Casterton HallUK 1989; 3–9
- Genazzani AR, Nappi G, Facchinetti F, et al. Central deficiency of beta-endorphin in alcohol addicts. J Clin Endocrinol Metabol 1982; 55: 583–587